EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Antibody‑drug conjugates in prostate cancer: Emerging strategies to enhance therapeutic index and current clinical landscape (Review)

Chadanfeng Yang, Limei Wang, Chen Gong, Dihao Lv, Haihao Li, Yinglong Huang, Jiting Li, Wujie Chen, Shi Fu, Zhiyong Tan, Mingxia Ding

Oncology Reports · 13.12.2024 · 53 (2)

DOI: 10.3892/or.2024.8854 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Oncology Reports, online erschienen am 13.12.2024. Verfasst von Chadanfeng Yang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, The Second Affiliated Hospital of Kunming Medical University, Kunming, Yunnan 650032, P.R. China. Hauptthemen laut MEDLINE: Immunoconjugates, Prostatic Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 107 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ImmunoconjugatesProstatic NeoplasmsHumansMale

Stichwörter der Autor:innen

antibody drug conjugatesmetastatic castration‑resistant prostate cancerprostate cancertarget therapytumor microenvironment

Substanzen

Immunoconjugates

Autor:innen und Institutionen

  • Department of Urology, The Second Affiliated Hospital of Kunming Medical University, Kunming, Yunnan 650032, P.R. China.

Zitieren

APA

Yang, C., Wang, L., Gong, C., Lv, D., Li, H., Huang, Y., Li, J., Chen, W., Fu, S., Tan, Z., & Ding, M. (2024). Antibody‑drug conjugates in prostate cancer: Emerging strategies to enhance therapeutic index and current clinical landscape (Review). Oncology Reports, 53(2). https://doi.org/10.3892/or.2024.8854

Vancouver

Yang C, Wang L, Gong C, Lv D, Li H, Huang Y, et al. Antibody‑drug conjugates in prostate cancer: Emerging strategies to enhance therapeutic index and current clinical landscape (Review). Oncology Reports. 2024;53(2). doi:10.3892/or.2024.8854

BibTeX
@article{Yang2024,
  author = {Yang, Chadanfeng and Wang, Limei and Gong, Chen and Lv, Dihao and Li, Haihao and Huang, Yinglong and Li, Jiting and Chen, Wujie and Fu, Shi and Tan, Zhiyong and Ding, Mingxia},
  title = {Antibody‑drug conjugates in prostate cancer: Emerging strategies to enhance therapeutic index and current clinical landscape (Review)},
  journal = {Oncology Reports},
  year = {2024},
  volume = {53},
  number = {2},
  doi = {10.3892/or.2024.8854}
}
Kostenlos starten →